Abstract
The rising prevalence of obesity and insulin resistance, a risk factor for type 2 diabetes (T2D), among adolescents is a growing public health concern. Understanding the metabolic underpinnings of adiposity and insulin resistance in adolescence can provide insights into the development of metabolic dysfunction, and potentially facilitate early intervention strategies to prevent the progression of these conditions into more severe metabolic disorders in adulthood. We explored the metabolic signatures of insulin resistance, Body Mass Index (BMI), and visceral adiposity in adolescents, in both fasting and postprandial states. A meal challenge was undertaken on 18-year-olds (154 females; 144 males), and their blood metabolites were profiled using Nuclear Magnetic Resonance spectroscopy (NMR). Least Absolute Shrinkage and Selection Operator (LASSO) regression was used for modeling and variable selection, in a sex-stratified manner. The results show distinct metabolic patterns between sexes, with males showing more pronounced postprandial responses and stronger associations between blood metabolome and insulin resistance, BMI, and visceral adiposity. Key metabolites such as lipid metabolites, Branched-Chain Amino Acids (BCAAs), glucose, and Glycoprotein Acetylation (GlycA) were selected as important metabolic entities in predicting insulin resistance and adiposity in adolescence. The findings underscore the complex interplay of metabolites with metabolic health and sex, and can pave the way for developing targeted interventions and preventive strategies specifically tailored to adolescents. Such interventions can potentially mitigate the risk of progression to more severe metabolic disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
COPSAC is supported by both private and public research funds, all of which are detailed on our website, www.copsac.com. Core support has been provided by the Lundbeck Foundation, the Danish Ministry of Health, the Danish Council for Strategic Research, and the Capital Region Research Foundation. No pharmaceutical companies were involved in this study. The funding agencies had no role in the design or conduct of the study, nor in the collection, management, interpretation of the data, or in the preparation, review, or approval of the manuscript. Additionally, MAR received funding from the Novo Nordisk Foundation (NNF21OC0068517).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Region Hovedstadens in Denmark (H-16040846) and the Danish Data Protection Agency (2015-41-3696).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Compared with the first revision, two changes have been made: 1) the order of the authors has been corrected 2) the margin of the pages with illustrations has been increased, to prevent overlap with the headings.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
